3-Phenoxybutan-1-amine | 547751-98-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-Phenoxybutan-1-amine
• CAS: 547751-98-4
• 化学式: C₁₀H₁₅NO
• 分子量: 165.23
• InChiKey: IFYRTIUVCKDVAA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• IMIDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS
  申请人：Knoll AG

  公开号：EP0705251A1

  公开（公告）日：1996-04-10
• PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDINE OR PYRIMIDINE DERIVATIVES FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION
  申请人：Targacept, Inc.

  公开号：EP1171127A2

  公开（公告）日：2002-01-16
• ARYL SUBSTITUTED ALKYLAMINES CAPABLE OF ACTIVATING NICOTINIC CHOLINERGIC RECEPTORS
  申请人：Targacept, Inc.

  公开号：EP1185513A2

  公开（公告）日：2002-03-13
• [EN] PHARMACEUTICAL COMPOSITIONS FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION<br/>[FR] COMPOSITIONS PHARMACEUTIQUES PERMETTANT D'INHIBER LA PRODUCTION ET LA SECRETION DE CYTOKINE
  申请人：TARGACEPT INC

  公开号：WO2000062767A2

  公开（公告）日：2000-10-26

  Pharmaceutical compositions incorporate compounds that affect cytokine production and/or secretion. Such compounds include aryl substituted olefinic amine compounds, pyridyloxylalkylamines and phenoxyalkylamines, and aryl substituted amine compounds, such as 3-aminophenyl amine compounds. Such pharmaceutical compositions can be used for treating a wide variety of conditions, diseases and disorders, and particularly those associated with dysfunction of cytokine production and/or secretion. Of particular interest are pharmaceutical compositions useful for preventing and treating conditions, diseases and disorders associated with undesirably high levels of cytokine production and/or secretion. Such pharmaceutical compositions are useful for treating the effects of inflammatory bowel disease, inflammation, arthritis, cachexia in neoplastics diseases or associated with AIDS, and autoimmune diseases.
• [EN] PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE<br/>[FR] COMPOSITIONS PHARMACEUTIQUES ET METHODES D'UTILISATION
  申请人：TARGACEPT INC

  公开号：WO2000071520A2

  公开（公告）日：2000-11-30

  Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof aryloxyalkylamines and arylthioalkylamines, including pyridyloxylalkylamines, phenoxyalkylamines, pyridylthiolalkylamines and phenylthioalkylamines of the formula (I) where X is nitrogen or carbon. X' are individually nitrogen, N-O or carbon.